Glenmark launches SUTIB (Sunitinib) –priced 96% lower than the innovator brand
Oral capsules, highly affordable at Rs. 7000 (50 mg), Rs. 3600 (25 mg) and Rs….
Glenmark Pharmaceuticals Ltd.
Glenmark introduces higher strength (400 mg) of FabiFlu(R) to reduce the pill burden of COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a…